石 磊,顧漢平
(淮安市淮陰醫(yī)院產(chǎn)科,江蘇 淮安 223300)
HDCP與子癇各期外周血D-二聚體及單側(cè)子宮動(dòng)脈血流比較
石 磊,顧漢平
(淮安市淮陰醫(yī)院產(chǎn)科,江蘇 淮安 223300)
目的 探討分析外周血D-二聚體及單側(cè)子宮動(dòng)脈血流在妊娠期高血壓疾病患者中比較的臨床意義。方法 回顧性分析于2015年2月至2016年7月來淮安市淮陰醫(yī)院就診的健康孕婦140例,妊娠期高血壓42例,輕度子癇前期68例,重度子癇前期48例,于患者妊娠10~14周和30~34周時(shí)測(cè)量外周血D-二聚體濃度,妊娠20~24周時(shí)測(cè)定分析子宮動(dòng)脈血流頻譜,對(duì)比分析四組患者的外周血D-二聚體和單側(cè)子宮動(dòng)脈血流。結(jié)果 四組患者10~14周D-二聚體水平明顯低于30~34周,差異有統(tǒng)計(jì)學(xué)意義(t值分別為-3.50、-2.98、-6.32、-5.61,均P<0.05)。健康孕婦組10~14周和30~34周檢測(cè)外周血D-二聚體水平明顯低于妊娠期高血壓組,差異有統(tǒng)計(jì)學(xué)意義(t值分別為-3.56、-2.55,均P<0.05)。妊娠期高血壓組兩次檢測(cè)外周血D-二聚體水平明顯低于輕度子癇前期組,差異有統(tǒng)計(jì)學(xué)意義(t值分別為-3.72、-3.42,均P<0.05)。輕度子癇前期組10~14周檢測(cè)外周血D-二聚體水平明顯低于重度子癇前期組,差異有統(tǒng)計(jì)學(xué)意義(t=-3.39,P<0.05)。輕度子癇前期組患者D-二聚體水平30~34周時(shí),與重度子癇前期組比較,差異無統(tǒng)計(jì)學(xué)意義(t=-1.84,P>0.05)。健康孕婦組S/D比值明顯低于妊娠期高血壓組、輕度子癇前期組和重度子癇前期組,差異有統(tǒng)計(jì)學(xué)意義(t值分別為-2.74、-5.26、-5.74,均P<0.05)。妊娠期高血壓組患者S/D比值明顯低于輕度子癇前期組和重度子癇前期組,差異有統(tǒng)計(jì)學(xué)意義(t值分別為-2.30、-2.91,均P<0.05)。輕度子癇前期組患者S/D比值明顯低于重度子癇前期組,差異有統(tǒng)計(jì)學(xué)意義(t=-2.05,P=0.04)。結(jié)論 外周血D-二聚體與子宮動(dòng)脈血流能夠反應(yīng)患者妊娠高血壓的嚴(yán)重程度,具有一定的診斷意義。
妊娠期高血壓疾病;D-二聚體;單側(cè)子宮動(dòng)脈血流;S/D比值
妊娠期高血壓疾病(hypertensive disorders complicating pregnancy,HDCP)是一組妊娠與血壓升高并存的疾病,發(fā)病率較高,常發(fā)生于妊娠20周后,患者常合并有蛋白尿、水腫、抽搐等[1-2]?;颊叽嬖谀到y(tǒng)的改變,凝血因子和凝血酶顯著增加,處于病理性高凝狀態(tài)。D-二聚體是一種纖維蛋白原的降解產(chǎn)物,能夠反應(yīng)纖溶酶活體的性質(zhì)和繼發(fā)性纖溶活性的強(qiáng)度。HDCP的患者胎盤與子宮血流減少、血管阻力增大,使用彩超多普勒血流頻譜圖能夠有效反應(yīng)子宮與胎盤循環(huán)的總阻力。本次研究通過對(duì)比分析HDCP患者與正常孕婦血漿D-二聚體水平及單側(cè)子宮動(dòng)脈血流,探討其臨床意義。
1.1一般資料
回顧性分析于2015年2月至2016年7月來淮安市淮陰醫(yī)院產(chǎn)科就診的健康孕婦140例,單胎,無內(nèi)外科疾病,年齡22~34歲,平均年齡(27.41±4.63)歲。HDCP患者42例,年齡22~35歲,平均年齡(28.52±5.38)歲。輕度子癇前期患者68例,年齡23~32歲,平均年齡(37.17±3.23)歲。重度子癇前期患者48例,年齡25~32歲,平均年齡(27.80±2.16)歲。四組患者年齡比較差異無統(tǒng)計(jì)學(xué)意義(均P>0.05),有可比性。所有患者均無既往肝腎疾病,近期未使用影響凝血纖溶活性的藥物,無慢性高血壓,無血液系統(tǒng)疾病史。所有患者及家屬均知情同意,均簽署知情同意書。本次研究經(jīng)本院醫(yī)學(xué)倫理學(xué)委員會(huì)批準(zhǔn)。
1.2方法
1.2.1外周血D-二聚體
于妊娠10~14周和30~34周時(shí),抽取四組患者靜脈血1.80mL,加入109mmol/L枸櫞酸鈉0.20mL抗凝,混勻,運(yùn)用離心機(jī)3 000r/min離心10min,分離血漿待測(cè)。使用ELISA雙抗體夾心法測(cè)定母體外周血D-二聚體濃度,操作步驟嚴(yán)格按照試劑盒(上海捷門生物技術(shù)公司)說明進(jìn)行,應(yīng)用酶標(biāo)比色儀,根據(jù)曲線得出D-二聚體含量。
1.2.2子宮動(dòng)脈血流
于妊娠20~24周使用西門子公司Acuson-Sequoias IZ型Doppler超聲診斷儀測(cè)定所有患者子宮動(dòng)脈多普勒參數(shù),腹部探頭,探頭頻率4.00MHz,發(fā)射功率<10Mw/cm2。測(cè)量收縮期峰值速度(S)/舒張期血流速度(D)比值,使用B超監(jiān)測(cè)單側(cè)子宮動(dòng)脈切跡。觀察四組患者子宮動(dòng)脈的血流動(dòng)力學(xué)變化。
1.3統(tǒng)計(jì)學(xué)方法
2.1外周血D-二聚體比較
四組患者10~14周D-二聚體水平明顯低于30~34周,差異有統(tǒng)計(jì)學(xué)意義(均P<0.05)。健康孕婦組10~14周和30~34周檢測(cè)外周血D-二聚體水平明顯低于妊娠期高血壓組,差異有統(tǒng)計(jì)學(xué)意義(t值分別為-3.56、-2.55,均P<0.05)。妊娠期高血壓組兩次檢測(cè)外周血D-二聚體水平明顯低于輕度子癇前期組,差異有統(tǒng)計(jì)學(xué)意義(t值分別為-3.72、-3.42,均P<0.05)。輕度子癇前期組10~14周檢測(cè)外周血D-二聚體水平明顯低于重度子癇前期組,差異有統(tǒng)計(jì)學(xué)意義(t=-3.39,P<0.05)。輕度子癇前期組患者D-二聚體水平30~34周時(shí),與重度子癇前期組比較,差異無統(tǒng)計(jì)學(xué)意義(t=-1.84,P>0.05),見表1。
2.2收縮期峰值速度/舒張期血流速度比值比較
健康孕婦組S/D比值明顯低于妊娠期高血壓組、輕度子癇前期組和重度子癇前期組,差異有統(tǒng)計(jì)學(xué)意義(t值分別為-2.74、-5.26、-5.74,均P<0.05)。妊娠期高血壓組患者S/D比值明顯低于輕度子癇前期組和重度子癇前期組,差異有統(tǒng)計(jì)學(xué)意義(t值分別為-2.30、-2.91,均P<0.05)。輕度子癇前期組患者S/D比值明顯低于重度子癇前期組,差異有統(tǒng)計(jì)學(xué)意義(t=-2.05,P=0.04),見表2。
組別 例數(shù)(n)10~14周30~34周tP健康孕婦 1400.12±0.040.36±0.81-3.50<0.05妊娠期高血壓420.17±0.15a0.79±1.34a-2.98<0.05輕度子癇前期680.35±0.29ab2.12±2.29ab-6.32<0.05重度子癇前期480.58±0.44abc3.02±2.98abc-5.61<0.05
注:a表示與健康孕婦組比較,P<0.05;b表示與妊娠期高血壓組比較,P<0.05;c表示與輕度子癇前期組比較,P<0.05。
組別例數(shù)(n)S/D值健康孕婦1402.14±0.43妊娠期高血壓422.33±0.24a輕度子癇前期682.43±0.21ab重度子癇前期482.56±0.46abc
注:a表示與健康孕婦組比較,P<0.05.b表示與妊娠期高血壓組比較,P<0.05;c表示與輕度子癇前期組比較,P<0.05。
孕婦隨著懷孕時(shí)間的延長,女性體內(nèi)凝血成分強(qiáng)化,纖維蛋白溶解活性弱化,導(dǎo)致機(jī)體出現(xiàn)高凝狀態(tài)。妊娠期高血壓疾病與正常妊娠孕婦的血液均處于高凝狀態(tài),發(fā)生血栓栓塞的風(fēng)險(xiǎn)大大提高。正常孕婦D-二聚體含量明顯低于妊娠期高血壓組,提示妊娠期高血壓疾病的孕婦血栓形成的發(fā)生率明顯增高。D-二聚體是纖溶亢進(jìn)的分子標(biāo)志物之一,能夠直接反應(yīng)纖溶酶活體的性質(zhì),提示機(jī)體處于高凝狀態(tài)。D-二聚體在機(jī)體處于生理性高凝狀態(tài)及各種血栓形成性疾病時(shí)均有提高[3]。
3.1 D-二聚體水平比較
本次研究結(jié)果表明,四組患者10~14周D-二聚體水平明顯低于30~34周,D-二聚體水平隨孕周上升而升高,提示所有患者均處于病理性高凝狀態(tài),處于繼發(fā)性纖溶增強(qiáng)狀態(tài),這種改變有利于產(chǎn)后快速有效止血,但大出血發(fā)生時(shí),容易導(dǎo)致彌散性血管內(nèi)凝血的發(fā)生。10~14周與30~34周時(shí),重度子癇前期組D-二聚體水平高于輕度子癇前期組,高于妊娠期高血壓組,高于健康孕婦組。這一研究結(jié)果與王國杰等[4]的研究結(jié)果一致,妊娠期高血壓疾病患者的外周血D-二聚體水平明顯高于正常孕婦,且隨癥狀的加重水平升高。提示孕婦外周血D-二聚體水平異常,明顯高于同期孕婦時(shí),孕婦妊娠期高血壓疾病的發(fā)生率明顯提高,應(yīng)提高警惕。外周血D-二聚體水平過度升高時(shí),表明患者形成血栓的概率增高,可能處于血栓前期或血栓狀態(tài)。妊娠高血壓疾病患者更容易發(fā)生DIC和形成血栓[5-7]。李秋粉等[8]認(rèn)為,胎盤脫落、死胎滯留和妊娠高血壓綜合征等,常伴有患者凝血功能紊亂。臨床上應(yīng)對(duì)妊娠期高血壓疾病孕婦進(jìn)行D-二聚體水平檢測(cè),能夠有效監(jiān)測(cè)、預(yù)防和治療各種產(chǎn)科并發(fā)癥。對(duì)D-二聚體含量過高的患者,應(yīng)進(jìn)行早期干預(yù),有效降低患者并發(fā)癥的發(fā)生,保障母嬰安全。
3.2 S/D比值比較
子宮動(dòng)脈彩超頻譜波形,能夠有效反映子宮與胎盤循環(huán)的總阻力。正常妊娠時(shí)滋養(yǎng)細(xì)胞入侵逐漸取代血管內(nèi)皮細(xì)胞,使血管擴(kuò)大,血流增加,能夠更好地營養(yǎng)胎兒,入侵程度可達(dá)子宮肌層內(nèi)的1/3[9]。妊娠期高血壓疾病的患者,機(jī)體處于病理狀態(tài),滋養(yǎng)細(xì)胞的侵蝕受到抑制,入侵僅達(dá)蛻膜血管,少數(shù)血管不發(fā)生重塑,導(dǎo)致子宮肌層螺旋動(dòng)脈擴(kuò)張不夠或不擴(kuò)張,導(dǎo)致子宮動(dòng)脈血流阻力增加,出現(xiàn)持續(xù)的子宮及胎盤血流高抵抗,導(dǎo)致母體與胎兒間物質(zhì)交流障礙,胎兒發(fā)育和生存受阻[10]。本次研究結(jié)果表明,健康妊娠組子宮動(dòng)脈血流S/D比值最低,低于其余三組,妊娠期高血壓疾病的患者隨疾病嚴(yán)重程度加大,S/D比值增高。這一研究結(jié)果與吳冬玲[11]的研究結(jié)果一致。
綜上所述,外周血D-二聚體與子宮動(dòng)脈血流能夠反應(yīng)患者妊娠高血壓的嚴(yán)重程度,具有一定的診斷意義。
[1]李美江, 李妹燕. 妊娠期高血壓疾病及并發(fā)癥與母嬰結(jié)局的關(guān)系[J].中國婦幼健康研究,2013,24(3):345-346,377.
[2]ElFarra J, Bean C, Martin J N Jr.Management of hypertensive crisis for the obstetrician/gynecologist[J]. Obstet Gynecol Clin North Am, 2016,43(4):623-637.
[3]Guntupalli K K, Karnad D R, Bandi V,etal. Critical illness in pregnancy: part II: common medical conditions complicating pregnancy and puerperium[J]. Chest, 2015,148(5):1333-1345.
[4]王國杰, 張灼錦. 血漿D-二聚體檢測(cè)對(duì)下肢深靜脈血栓的早期診斷價(jià)值[J].實(shí)用醫(yī)學(xué)雜志,2012,28(14):2368-2370.
[5]Ai L, Lan X, Wang L,etal. Clinical study on the influence of phloroglucinol on plasma angiotensin II and D-Dimer index in patients with severe pregnancy-induced hypertension[J]. Pak J Pharm Sci, 2016,29(4 Suppl):1375-1378.
[6]Loskutova T A, Turchin V N. Prognosis of hypertensive disorders in pregnancy[J]. Lik Sprava, 2013,(7):25-31.
[7]Manolov V, Marinov B, Masseva A,etal. Plasma D-dimer levels in preeclampsia[J]. Akush Ginekol (Sofiia), 2014,53(Suppl 2):15-18.
[8]李秋粉, 劉海榮, 方東霞. D-二聚體在孕晚期及妊娠期高血壓疾病檢測(cè)的意義[J].中外醫(yī)療,2015,34(2):28-29.
[9]Pinheiro M B, Carvalho M G, Martins-Filho O A,etal. Severe preeclampsia: are hemostatic and inflammatory parameters associated[J]. Clin Chim Acta, 2014,427:65-70.
[10]沈永紅, 袁文慧, 李俊英. 子癇前期患者血清APN和sFlt-1水平與子宮螺旋動(dòng)脈血流變化關(guān)系[J].中國婦幼健康研究,2016,27(1):35-37.
[11]吳冬玲. D-二聚體及子宮動(dòng)脈血流在妊娠期高血壓疾病中的意義[J].復(fù)旦學(xué)報(bào)(醫(yī)學(xué)版),2015,42(6):776-779.
[專業(yè)責(zé)任編輯:楊文方]
Comaprison and clinical significance of D-dimer in peripheral blood and unilateral uterine artery blood flow in pregnant women with gestational hypertension, mild preeclampsia and severe preeclampsia
SHI Lei, GU Han-ping
(Department of Obstetrics, Huai'an Huaiyin Hospital, Jiangsu Huai’an 223300, China)
Objective To investigate clinical significance of D-dimer in peripheral blood and unilateral uterine artery blood flow in patients with hypertensive disorder complicating pregnancy. Methods Retrospective analysis was conducted on 140 cases of healthy pregnant women, 42 cases of gestational hypertension, 68 patients with mild preeclampsia and 48 cases of severe preeclampsia treated in Huai’an Huaiyin Hospital from February 2015 to July 2016. Concentration of D-dimer in peripheral blood was measured respectively at 10-14 and 30-34 gestational weeks. Uterine artery Doppler blood flow spectrum was measured and analyzed at 20-24 gestational weeks. Peripheral blood D-dimer and unilateral uterine artery blood flow was compared and analyzed in four groups. Results D-dimer in four groups at 10-14 gestational weeks was significantly lower than that at 30-34 weeks, and difference was statistically significant (tvalue was -3.50, -2.98, -6.32 and -5.61, respectively, allP<0.05). D-dimer level in peripheral blood of healthy pregnant women was significantly lower than that of patients in gestational hypertension group at 10-14 weeks and 30-34 weeks with statistically significant difference (tvalue was -3.56 and -2.55, respectivley, bothP<0.05). D-dimer level in gestational hypertension group was significantly lower than that in mild preeclampsia group for two tests, and difference was statistically significant (tvalue was -3.72 and -3.42, respectively, bothP<0.05). D-dimer level tested at 10-14 gestational weeks in mild preeclampsia group was significantly lower than that in severe preeclampsia group with statistically significant difference (t=-3.39,P<0.05). There was no significant difference in D-dimer level at 30-34 weeks between mild and severe preeclampsia groups (t=-1.84,P>0.05). S/D in healthy pregnant group was significantly lower than that in gestational hypertension group, mild preeclampsia group and severe preeclampsia group, and difference was statistically significant (tvalue was -2.74, -5.26 and -5.74, respectively, allP<0.05). S/D in hypertension group was significantly lower than that in mild preeclampsia group and severe preeclampsia group, and difference was statistically significant (tvalue was -2.30 and -2.91, respectively, bothP<0.05). S/D in mild preeclampsia group was significantly lower than that in severe preeclampsia group, and difference was statistically significant (t=-2.05,P=0.04). Conclusion Peripheral blood D-dimer and uterine artery blood flow can reflect severity of pregnancy induced hypertension, and has certain diagnostic significance.
hypertensive disorder complicating pregnancy; D-dimer; unilateral uterine artery blood flow; S/D
2017-01-04
石 磊(1982-),男,主治醫(yī)師,主要從事產(chǎn)科臨床工作。
顧漢平,副主任醫(yī)師。
10.3969/j.issn.1673-5293.2017.07.039
R714.2
A
1673-5293(2017)07-0871-03